Neurocritical Care

, Volume 2, Issue 3, pp 296–299

Reversal of locked-in syndrome with anticoagulation, induced hypertension, and intravenous t-PA

Practical Pearl

Abstract

Introduction: Widespread use of intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke is limited by multiple contraindications to its use.

Case report: This article describes a patient with stuttering symptoms of pontine ischemia caused by vertebrobasilar dissection who suddenly deteriorated into a locked-in state 32 hours after symptom onset. The quadriparesis was successfully reversed within 3 hours of onset with the combination of pharmacologically induced hypertension, anticoagulation, and intravenous t-PA.

Discussion: Even in the face of numerous contraindications (including hypertension, anti-coagulation, and treatment beyond 3 hours of symptom onset), intravenous t-PA can be used successfully in carefully selected cases.

Key Words

Dissection vertebral artery basilar artery thrombolytic therapy locked-in syndrome anticoagulants hypertension 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995). Tissue plasminogen activator in acute ischemic stroke. NEJM 1995;333:1581–1587.CrossRefGoogle Scholar
  2. 2.
    Gasecki AP, Graffagnino C, Hachinski V. Tissue plasminogen activator in vertebral artery dissection. Can J Neurosci 1997;24:151–154.Google Scholar
  3. 3.
    Derex L, Nighoghossian N, Turjman F, et al. Intravenous tPA in acute ischemic stroke related to internal carotid artery dissection. Neurology 2000;54:2159–2161.PubMedGoogle Scholar
  4. 4.
    Arnold M, Nedeltchev K, Sturzenegger M, et al. Thrombolysis in patients with acute stroke caused by cervical artery dissection. Arch Neurol 2002;59:549–553.PubMedCrossRefGoogle Scholar
  5. 5.
    Leistner S, Hartmann A, Marx P, Koennecke HC. Successful thrombolytic treatment of intracranial carotid occlusion due to dissection. Eur Neurol 2001;45:284,285.PubMedCrossRefGoogle Scholar
  6. 6.
    Rudolf J, Neveling M, Grond M, Schmulling S, Stenzel C, Heiss WD. Stroke following internal carotid artery occlusion—a contraindication for thrombolysis. Eur J Neurol 1999;6:51–55.PubMedCrossRefGoogle Scholar
  7. 7.
    Rordorf G, Koroshetz WJ, Ezzeddine MA, Segal AZ, Buonanno F. A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 2001;55:1210–1213.Google Scholar
  8. 8.
    Wojner AW, Gerami Z, Nosser EA, Shaw S, Malkoff M, Alexandrov AV. Heads down: lower head position is better in acute ischemic stroke [abstract]. Stroke 2003;34:278.Google Scholar
  9. 9.
    Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598–2605.PubMedGoogle Scholar
  10. 10.
    IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904–911.CrossRefGoogle Scholar
  11. 11.
    Lyrer P, Engelter S. Antithrombotic drugs for carotid artery dissection. Cochrane Database Systemic Review 2000;(4):CD00025.Google Scholar
  12. 12.
    Schevink WI. The treatment of spontaneous carotid and vertebral artery dissections. Curr Opin Cardiol 2000;15:316–321.CrossRefGoogle Scholar
  13. 13.
    Koch S, Romano JG, Bustillo IC, Concha M, Forteza AM. Anticoagulation and microembolus detection in a case of internal carotid artery dissection. J Neuroimag 2001;11:63–66.CrossRefGoogle Scholar
  14. 14.
    Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282:2019–2026.PubMedCrossRefGoogle Scholar
  15. 15.
    Rother J, Schellinger PD, Gass A, et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke 2002;33:2438–2445.PubMedCrossRefGoogle Scholar
  16. 16.
    Stapf C, Marshall RS, Mohr JP, et al. Late intra-arterial thrombolysis. Eur J Med Res 2000;5:303–306.PubMedGoogle Scholar
  17. 17.
    Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ. Intra-arterial thromblytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988;19:1216–1222.PubMedGoogle Scholar
  18. 18.
    Brandt T, von Kummer R, Muller-Kuppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996;27:875–881.PubMedGoogle Scholar

Copyright information

© Humana Press Inc 2005

Authors and Affiliations

  1. 1.The Neurological Intensive Care Unit, Department of NeurologyColumbia University College of Physicians and SurgeonsNew York
  2. 2.Department of NeurosurgeryColumbia University College of Physicians and SurgeonsNew York
  3. 3.Department of Neurology and Neurosciences, Division of Cerebrovascular Disease and Endovascular SurgeryUniversity of Medicine and Dentistry, New JerseyNewark

Personalised recommendations